RxDoctor Payments Data

Mary Nashert, NP

Acute Care · Downers Grove, ILNPI 1710134713

Payments from drug & device makers

$1,343in general payments, 2019–2025

Across 41 payments — averaging $32.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$427
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$342
  • E.r. Squibb & Sons, L.L.C.$146
  • Novartis$132
  • Medtronic$113
  • Boston Scientific$96
  • plus $86 from 4 others

What the payments were for

  • Food & beverage$1,343100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,343 in reported general payments places this provider in the 80th percentile of 461 acute care providers in Illinois.

See all acute care providers in Illinois

Medicare billing

Part B allowed, 2024
$44,885
Medicare patients
309
Services billed
633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$60,276
JardianceEmpagliflozin17$22,841
XareltoRivaroxaban26$16,918
Repatha SyringeEvolocumab19$10,406
BrilintaTicagrelor12$8,408
Valsartan66$1,928
Ezetimibe51$1,097
Metoprolol Succinate87$1,025
ClopidogrelClopidogrel Bisulfate87$1,009
Enoxaparin Sodium20$828
Atorvastatin Calcium108$816
Losartan Potassium70$776
Nebivolol Hcl13$705
Amlodipine Besylate72$638
Ranolazine ErRanolazine13$562

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$29$16,91826 claims
AstraZenecaBrilinta$15$8,40812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 461 acute care providers in Illinois.

Other acute care in Downers Grove

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →